JOURNAL ARTICLE

Artificial uteruses on the horizon.

  • Published In: New Scientist, 2023, v. 260, n. 3471. P. 13 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Klein, Alice 3 of 3

Abstract

The US Food and Drug Administration (FDA) may soon approve the first human trial of an artificial uterus, following successful trials in premature lambs. Artificial uteruses are designed to support babies born extremely prematurely, who often struggle to breathe properly and have a low survival rate. The EXTEND system, which consists of a "bio-bag" filled with lab-made amniotic fluid, has shown promise in animal studies. The FDA has convened a meeting to discuss the potential risks and benefits of a first-in-human trial, and the development of the technology has sparked speculation about the possibility of growing babies from in vitro fertilization embryos. However, researchers argue that this is currently a "pipe dream" due to the limitations of artificial uteruses. [Extracted from the article]

Additional Information

  • Source:New Scientist. 2023/12, Vol. 260, Issue 3471, p13
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2023
  • ISSN:0262-4079
  • Accession Number:174396541
  • Copyright Statement:Copyright of New Scientist is the property of New Scientist Ltd. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.